|
|
 |
|
Viewing report
|
|
 |
 |
Harnessing Patient Power: Strategies For Speeding Drug Approval, Building And Retaining Market Share
Business Insights, Jan 2004, Pages: 110
Relationships between the pharmaceutical industry and patient groups have changed drastically during the past two decades, they are no longer restricted to financial contributions to create goodwill, with no expectation of a measurable return for the company. The management report, Harnessing Patient Power: Strategies for speeding drug approval, building and retaining market share, outlines the developments in pharma-patient group alliances and provides a guide for maximizing their impact across a range of pharma activities: clinical trial recruitment, product launches, CME programs, disease awareness and education initiatives. Advocacy groups are now more aware of how to leverage their influence, but still seek financial assistance, cutting-edge information about clinical trials, new therapies, professional or technical support, and other in-kind contributions that help them better serve their patient communities. The report uses detailed case studies to pinpoint how pharma companies can convert such relationships into important business tools to meet their corporate objectives.
Customers who bought this item also bought
Online Patient Recruitment And Its Impact On Patient Relationship Management
Companion Diagnostics - Global Strategic Business Report
Molecular Diagnostics - Technologies, Markets and Companies
Clinical Trial Recruitment Strategies: Optimizing Patient Recruitment and Retention in Late Stage Clinical Trials
Patient Recruitment and Retention in Clinical Trials: Emerging Strategies in Europe, the US and Asia
Molecular Diagnostics in Cancer Testing
Multi-client Study: Opportunities Assessment for Hepatitis C Therapeutics Market in India
Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
Biomarker and Diagnostic Opportunities Associated with Targeted Cancer Therapies
Clinical Trial Patient Recruitment: Accelerate Enrollment, Increase Retention and Reduce Costs
|
 |
|
|